May 13, 2021 Reyon and MDimune has announced the signing of a partnership focused on mRNA delivery for antivirus vaccine and rare genetic disorder.
May 11, 2021 Navigo Proteins and MDimune announced a technology collaboration to achieve tissue-targeting of extracellular vesicles (EVs), Affilin®-mediated delivery of CDVs specifically to solid tumor targets.
Apr 5, 2021 MDimune and Evercyte GmbH announced a strategic collaboration to develop tumor-targeted drug delivery by combining their technologies.
Mar 15, 2021 ExonanoRNA and MDimune have entered into a service agreement to develop targeted siRNA therapy in oncology applications.
Oct 30, 2020 MDimune announced the signing of research agreements with Pohang University of Science and Technology (POSTECH), Konkuk University, and Catholic University.
Oct 28, 2020 Plug and Play, headquartered in Silicon Valley, California, announced that MDimune will be partnering with Lonza. MDimune is among 11 Batch 5 startups to join the global startup incubation program ‘Startup Creasphere’.
Oct 26, 2020 BioDrone® platform technology was awarded the “Best Cell Therapy Technology of the Year” at the annual Cell Therapy World Asia 2020 conference.
Apr 30, 2020 MDimune Signed a Research Collaboration Agreement with Paracelsus Medical University for EV Therapeutics Development.
Apr 8, 2020 MDimune Received U.S. Patent on BioDrone® Technology.
Copyright © 2021 BioDrone Therapeutics Inc. - All Rights Reserved.